Figure 1
Figure 2
Figure 3
Future prospects of videoconferencing, N = 816_
| Question | ‘Yes’ (%) | ‘No’ (%) | ‘I don’t know’ (%) |
|---|---|---|---|
| Do you see any useful applications for videoconferencing in outpatient speech and language therapy? | 661 (81) | 89 (11) | 66 (8) |
| Can you imagine using videoconferencing in addition to frequency enhancement if this would enable better and/or faster therapy success? | 646 (79) | 113 (14) | 57 (7) |
| Can you imagine conducting some therapy sessions in the therapy process online, without affecting therapy success? | 676 (83) | 82 (10) | 58 (7) |
| Can you imagine conducting some therapy sessions in the therapy process online, without affecting the relation between you and your patient? | 662 (81) | 96 (12) | 58 (7) |
| ‘Yes’ (%) | ‘No’ (%) | ‘I don’t care’ (%) | |
| Should videoconferencing be included in standard healthcare? | 636 (78) | 137 (17) | 43 (5) |
Participants' characteristics_
| Item | Response | Frequency (%) | Mean (SD) |
|---|---|---|---|
| Gender (n = 816) | Female | 771 (94.5) | |
| Male | 45 (5.5) | ||
| Age in years (n = 815) | 44 (± 11) | ||
| Years of working experience (n = 812) | 17 (± 10) | ||
| Professional status (n = 816) | Practice owner | 523 (64.1) | |
| Employee | 259 (31.7) | ||
| Freelancer | 20 (2.5) | ||
| Other | 14 (1.7) | ||
| Participation by state (n = 816) | Bavaria | 165 (20.2) | |
| North Rhine-Westphalia | 149 (18.3) | ||
| Baden-Württemberg | 99 (12.1) | ||
| Lower Saxony | 81 (9.9) | ||
| Hesse | 66 (8.1) | ||
| Rhineland-Palatinate | 61 (7.5) | ||
| Berlin | 48 (5.9) | ||
| Hamburg | 39 (4.8) | ||
| Saxony | 23 (2.8) | ||
| Brandenburg | 21 (2.6) | ||
| Schleswig-Holstein | 19 (2.3) | ||
| Saarland | 14 (1.7) | ||
| Mecklenburg-West Pomerania | 12 (1.5) | ||
| Thuringia | 8 (1) | ||
| Saxony-Anhalt | 8 (1) | ||
| Bremen | 3 (0.4) |
Use and suitability of videoconferencing_ (Please note: The specification in parentheses corresponds to the indication codes of the German ‘Heilmittelkatalog’ (therapeutic remedies catalogue)_ The dashes in the first column indicate that the answer options were not available for this question_
| Disorder | Frequency used (%) n = 707 | Frequency inappropriate (%) n = 816 |
|---|---|---|
| Language development disorder (SP1) | 565 (80) | 139 (17) |
| Articulation disorder (SP3) | 484 (70) | 139 (13) |
| Aphasia or dysphasia (SP5) | 299 (42) | 75 (9) |
| Oral swallowing disturbance (SCZ) | 271 (38) | 160 (20) |
| Speech motor dysfunction (SP6) | 270 (38) | 89 (11) |
| Functional voice disorder (ST2) | 262 (37) | 121 (15) |
| Orofacial dysfunction (OFZ) | 236 (33) | 107 (13) |
| Speech disorder (SPZ) | 188 (27) | 57 (7) |
| Stuttering (RE1) | 184 (26) | 88 (11) |
| Auditory perceptual disorder (SP2) | 174 (25) | 207 (25) |
| Organic voice disorder (ST1) | 163 (23) | 136 (17) |
| Rumbling (RE2) | 50 (7) | 88 (11) |
| Speech disorders in high degree hearing loss or deafness (SP4) | 42 (6) | 346 (42) |
| Psychogenic dysphonia (ST4) | 32 (5) | 218 (27) |
| Rhinophony (SF) | 32 (5) | 117 (14) |
| Psychogenic aphonia (ST3) | 26 (4) | 239 (30) |
| Dysphagia (SC1) | - | 435 (53) |
| Damage to the head and neck section (SC2) | - | 291 (36) |
| Nothing applies | - | 227 (28) |